Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
LEAFLET: INFORMATION FOR THE USER
HYPERICUM ARKOPHARMA hard capsules
Hypericum perforatum L.
Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.
Follow the exact administration instructions contained in this leaflet or as directed by your pharmacist, doctor, or nurse.
- Keep this leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet.
- You should consult a doctor if your condition worsens or does not improve after 28 days of treatment.
Contents of the leaflet
1. What HYPERICUM ARKOPHARMA is and what it is used for
2. What you need to know before you start taking HYPERICUM ARKOPHARMA
3. How to take HYPERICUM ARKOPHARMA
4. Possible side effects
5. Storage of HYPERICUM ARKOPHARMA 6. Package contents and additional information.
Herbal medicine for the symptomatic treatment of low mood, lack of interest, fatigue, and sleep disturbances.
You should consult a doctor if your condition worsens or does not improve after 28 days.
Do not take HYPERICUM ARKOPHARMA
Warnings and precautions
Consult your pharmacist, doctor, or nurse before starting HYPERICUM ARKOPHARMA.
If you are taking HYPERICUM ARKOPHARMA, avoid intense UV exposure (prolonged sun exposure or tanning beds).
Women using oral contraceptives should not use this medicine simultaneously, as it may cause intermenstrual bleeding and reduce the effectiveness of contraceptives.
Avoid intense solar radiation or artificial ultraviolet radiation while taking this medicine. Its use is not recommended during phototherapy treatments (UVA light therapy) or if undergoing any photodiagnostic tests, particularly in light-skinned individuals, as it may cause sunburn-like reactions on exposed skin.
If you have been diagnosed with depression and are being treated with psychotropic drugs, selective serotonin reuptake inhibitors, or triptans, do not use this medicine.
Stop taking this medicine 10 days before surgery or any planned clinical intervention to avoid potential interactions with other medicines during general or local anesthesia.
Children and adolescents
Children and adolescents under 18 years should not use this medicine.
Use of HYPERICUM ARKOPHARMA with other medicines
Some components of hypericum (Hypericum perforatum L.) may reduce the therapeutic effects of other medicines when taken simultaneously. These include medicines recommended by your doctor and over-the-counter medications.
Patients taking the following medicines should not start hypericum preparations without consulting their doctor or pharmacist:
For more information, consult the following list:
Do not take this medicine if you are being treated with any of the medicines listed below:
Concomitant treatment of HYPERICUM ARKOPHARMA with anticoagulants (such as phenprocoumon, warfarin, clopidogrel, acetylsalicylic acid, and other non-steroidal anti-inflammatory drugs) may increase their effect.
HYPERICUM ARKOPHARMA may affect the metabolism of other medicines, potentially altering their potency and/or duration of effect. Therefore, consult your doctor or pharmacist before taking HYPERICUM ARKOPHARMA with other treatments.
Inform your doctor or pharmacist if you are taking or have recently taken any other medication, including those obtained without a prescription.
Also inform your doctor or pharmacist about any suspected changes in the effects of medications you are taking alongside HYPERICUM ARKOPHARMA.
Taking HYPERICUM ARKOPHARMA with food and drinks
Food and beverages have no influence on the effect of the medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult your pharmacist or doctor before using this medicine. Its use is not recommended in these circumstances.
Driving and using machines
No studies have been conducted on the ability to drive and use machines.
Follow the administration instructions for the medicine as described in this leaflet or as directed by your pharmacist, doctor, or nurse. If in doubt, consult your pharmacist, doctor, or nurse.
The recommended dose is:
Adults: take 2 capsules, 2 or 3 times a day with a glass of water.
It is advisable to take the doses at the same times every day.
This medicine is for oral use.
The treatment duration is 6 weeks.
The effect of the medicine usually appears after 4 weeks. If symptoms persist, you should consult a healthcare professional.
Once the package is opened, remove the absorbent sachet, which is not suitable for human consumption and must not be ingested.
Use in children and adolescents
Do not use in children and adolescents under 18 years of age.
If you take more HYPERICUM ARKOPHARMA than you should
If you have taken an excessive dose of HYPERICUM ARKOPHARMA, seizures or confusion may occur.
In case of an excessive dose of hypericum, protect yourself from sunlight or any other UV ray source for 1-2 weeks.
In case of overdose or accidental ingestion, immediately consult your pharmacist or doctor, or call the Toxicology Information Service at 91 562 04 20, indicating the product and the quantity ingested.
If you forget to take HYPERICUM ARKOPHARMA
If you forget a dose, take the medicine as soon as possible and continue the treatment as prescribed. However, if it is close to the time for the next dose, it is better to skip the missed dose and wait for the next one. Never take a double dose to make up for the missed dose..
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
In rare cases, with a frequency affecting fewer than one in 1000 patients, digestive problems such as nausea, abdominal pain, diarrhea, loss of appetite, or skin reactions such as itching, irritation, redness (hives), and very rarely, sunburn-like reactions on skin exposed to intense sunlight or artificial radiation have been reported.
Headache, neuropathy, anxiety, dizziness, fatigue, mania, or allergies have also been reported, but the frequency of these occurrences is unknown.
Reporting adverse reactions:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information about the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store at a temperature above 25ºC.
Once opened, discard after 21 days.
Do not use HYPERICUM ARKOPHARMA after the expiration date stated on the package, following the abbreviation “EXP.” The expiration date refers to the last day of the indicated month.
Medicines should not be disposed of via wastewater or household waste. Take unused packages and medicines to the SIGRE Point at the pharmacy. If in doubt, ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.
Composition of HYPERICUM ARKOPHARMA
Each capsule contains the active ingredient:
175 mg of hydroalcoholic dry extract of Hypericum perforatum L. herba (flowering tops of St. John's wort) (3.5-6:1) corresponding to: 0.27 mg to 0.46 mg of total hypericins, ≥ 10.5 mg of flavonoids, and 2.71 mg to 4.63 mg of hyperforin.
Extraction solvent: ethanol 60% m/m
Other ingredients (excipients): microcrystalline cellulose, magnesium stearate, colloidal anhydrous silica, and maltodextrin.
Capsule composition: hypromellose, titanium dioxide, and yellow iron oxide.
Product appearance and package contents
There is one presentation in bottles containing 42 capsules, with an absorbent sachet inside.
Once the container is opened, the absorbent sachet should be removed, as it is not suitable for human consumption and must not be ingested.
Marketing authorization holder and manufacturer:
Holder
Arkopharma LABORATORIES, S.A.U,
C/ Amaltea, 9
28045 MADRID
Manufacturer
ARKOPHARMA
LABORATOIRES PHARMACEUTIQUES
BP 28 – 06511 CARROS Cedex - FRANCE
Date of the last revision of this leaflet: September 2016
Detailed and updated information about this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Full name: HIPÉRICO ARKOPHARMA cápsulas duras
- Invented name part: HIPÉRICO ARKOPHARMA
- Scientific name part: Hypericum perforatum L.
- Strength part: 175 mg
- Pharmaceutical dose form part: hard capsules
Name usage: English ()
Authorised dose form:
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: active
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 79963
Region:
Marketing authorisation holder: Arkopharma LABORATORIOS, S.A.U,
Identifier:
Status: Active (2015-01-01)
Package 1 of 1
PMSWI: x
Description:
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 30 Blister (cardboard)
Containing:
Manufactured Item
Dose form: hard capsules
Unit of presentation: hard capsules
Ingredient
Role: active
Substance: Hypericum perforatum L.
Ingredient
Role: excipient
Substance: microcrystalline cellulose
Ingredient
Role: excipient
Substance: magnesium stearate
Ingredient
Role: excipient
Substance: colloidal hydrophobic silica
Ingredient
Role: excipient
Substance: maltodextrin
Administrable Product (1 of 1)
Dose form: Hard capsules
Unit of presentation: hard capsule
Route of administration:
Ingredient
Role: active
Substance: Hypericum perforatum L.
Ingredient
Role: excipient
Substance: microcrystalline cellulose
Ingredient
Role: excipient
Substance: magnesium stearate
Ingredient
Role: excipient
Substance: colloidal hydrophobic silica
Ingredient
Role: excipient
Substance: maltodextrin